SILO 8-K 2026-06-18

Silo Pharma, Inc. (SILO) 8-K dated 2026-06-18 — accession 0001213900-26-070212. This URL is the filing, not the SILO hub.

Silo Pharma, Inc. (SILO) is a biotechnology company listed on US.

Silo Pharma, Inc. filed a 8-K on 2026-06-18. Accession 0001213900-26-070212.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.

Not investment advice. The SILO SEC hub lists recent forms. The stock page is the research view.